TCGX Acquisition Corp. II closes $100 million IPO, lists as TCXB on Nasdaq
TCGX Acquisition Corp. II, a blank-check SPAC, closed its initial public offering of 10,000,000 Class A ordinary shares at $10.00 per share, raising $100,000,000 in gross proceeds, and placed the full amount in a U.S. trust account. The company will seek a business combination, with a focus on healthcare and healthcare-related industries, and shareholders' redemption rights depend on whether it completes a deal within 24 months.
Key points
- IPO of 10,000,000 Class A ordinary shares at $10.00 per share, closed October 19, 2026, for $100,000,000 in gross proceeds
- Concurrent private placement of 450,000 shares to the sponsor at $10.00 per share, for $4,500,000
- $100,000,000 placed in a trust account at Citibank, N.A.; funds are generally held until a business combination or redemption if none is completed within 24 months
- Shares to trade on Nasdaq Capital Market under ticker TCXB beginning October 16, 2026; investors receive no warrants
The filing
Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 19, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.